medical cannabis patient

Daily Marijuana Observer

Daily Marijuana Observer – Better Know a CTO

Our President and Chief Technology Officer, Dave Berg​ was recently featured in the The Daily Marijuana Observer​ – Get to know all about what makes Dave tick, and why he’s so passionate about Strainprint.

Strainprint Technologies

National Post – Open Letter To ACMPR Medical Cannabis Patients

National Post – Open Letter To ACMPR Medical Cannabis Patients Strainprint advocates for carving out and preserving our world class Medical Cannabis program. Read our letter posted in the National Post,  share, and let Finance Canada know that taxing medical cannabis is wrong! #donttaxmedicine

Canna Farms

Strainprint Launches Custom App Version For Canna Farms

Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.

Investing News

Investing News Network: Changing the Limitations of Cannabis Research

On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.

Strainprint Technologies

Strainprint Expands Coverage With the Addition of Harvest Medicine

Strainprint™ Technologies Ltd. Expands Nationwide Coverage With the Addition of Harvest Medicine to The Strainprint Community PRESS RELEASE Toronto, August 2, 2017 – Strainprint, the leader in cannabis data collection and strain efficacy reporting [analytics], is pleased to welcome Harvest Medicine cannabis clinic to its growing list of data customers. Based in Calgary, Alberta, Harvest […]

High Canada

High Canada – Innovation Within The Industry

July 22, 2017 – Strainprint was recently featured in High Canada. Our story focused on innovation within the industry.

Advisors

Strainprint Announces The Formation of A Board of Medical Advisors

Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.

Emblem

Strainprint Announces Partnership With Emblem Cannabis Corp.

Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.

Strainprint Technologies

Strainprint Closes Private Investment Round

Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.